StockWatch
·
 Medicinal Chemicals and Botanical Products
BuybackJun 16, 2026, 04:15 PM

Cronos Group Expands Share Buyback Program to $50M via TSX NCIB

AI Summary

Cronos Group Inc. announced the filing and acceptance of a normal course issuer bid (NCIB) with the Toronto Stock Exchange (TSX), expanding its previously approved share repurchase program. This allows repurchases on Canadian trading systems in addition to U.S. markets. The company intends to purchase for cancellation up to US$50 million or 18,712,918 common shares, representing approximately 5.02% of its outstanding shares. Cronos also obtained an exemption from the Ontario Securities Commission to facilitate repurchases on NASDAQ.

Key Highlights

  • Filed and accepted TSX Normal Course Issuer Bid (NCIB).
  • Share Repurchase Program aims to buy back up to US$50 million of common shares.
  • Maximum of 18,712,918 common shares to be repurchased.
  • Represents approximately 5.02% of 373 million outstanding shares as of June 1, 2026.
  • TSX NCIB daily purchase limit: 53,968 common shares (25% of ADTV).
  • Share Repurchase Program commenced May 14, 2026, and ends May 13, 2027.
  • Obtained NCIB Exemption from Ontario Securities Commission for NASDAQ repurchases.